Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Oncogene

Showing results (691-700 of 22,566) with videos related to

Pageof 2,257
Sort By:
Oncogene|May 30, 2006
Self-association of the transmembrane domain of RET underlies oncogenic activation by MEN2A mutationsS Kjaer, K Kurokawa, M Perrinjaquet, et al.
Oncogene|May 30, 2006
Downregulation of Fer induces PP1 activation and cell-cycle arrest in malignant cellsO Pasder, S Shpungin, Y Salem, et al.
Oncogene|May 30, 2006
EP2, a receptor for PGE2, regulates tumor angiogenesis through direct effects on endothelial cell motility and survivalM Kamiyama, A Pozzi, L Yang, et al.
Oncogene|November 1, 1991
Expression of activated rat neu oncogene is sufficient to induce experimental metastasis in 3T3 cellsD H Yu, M C Hung
Oncogene|November 1, 1991
v-erbA oncogene abrogates growth inhibition of chicken embryo fibroblasts induced by retinoic acidC Desbois, B Pain, C Guilhot, et al.
Oncogene|February 1, 1991
Repressed expression of the HER-2/c-erbB-2 proto-oncogene by the adenovirus E1a gene productsD H Yan, L S Chang, M C Hung
Oncogene|June 10, 2020
Gut microbiota modulation: a novel strategy for prevention and treatment of colorectal cancerWinnie Fong, Qing Li, Jun Yu
Oncogene|May 7, 2021
C/EBPβ is a MYB- and p300-cooperating pro-leukemogenic factor and promising drug target in acute myeloid leukemiaMaria V Yusenko, Amke Trentmann, Debora A Casolari, et al.
Oncogene|May 7, 2021
YTHDF2 is a potential target of AML1/ETO-HIF1α loop-mediated cell proliferation in t(8;21) AMLZe Chen, Yang-Liu Shao, Li-Li Wang, et al.
Oncogene|May 7, 2021
Correction: Role of androgen receptor splice variant-7 (AR-V7) in prostate cancer resistance to 2nd-generation androgen receptor signaling inhibitorsYezi Zhu, Susan L Dalrymple, Ilsa Coleman, et al.
Pageof 2,257

Showing results (691-700 of 22,566) with videos related to

Sort By:
Pageof 2,257
Oncogene|May 30, 2006
Self-association of the transmembrane domain of RET underlies oncogenic activation by MEN2A mutationsS Kjaer, K Kurokawa, M Perrinjaquet, et al.
Oncogene|May 30, 2006
Downregulation of Fer induces PP1 activation and cell-cycle arrest in malignant cellsO Pasder, S Shpungin, Y Salem, et al.
Oncogene|May 30, 2006
EP2, a receptor for PGE2, regulates tumor angiogenesis through direct effects on endothelial cell motility and survivalM Kamiyama, A Pozzi, L Yang, et al.
Oncogene|November 1, 1991
Expression of activated rat neu oncogene is sufficient to induce experimental metastasis in 3T3 cellsD H Yu, M C Hung
Oncogene|November 1, 1991
v-erbA oncogene abrogates growth inhibition of chicken embryo fibroblasts induced by retinoic acidC Desbois, B Pain, C Guilhot, et al.
Oncogene|February 1, 1991
Repressed expression of the HER-2/c-erbB-2 proto-oncogene by the adenovirus E1a gene productsD H Yan, L S Chang, M C Hung
Oncogene|June 10, 2020
Gut microbiota modulation: a novel strategy for prevention and treatment of colorectal cancerWinnie Fong, Qing Li, Jun Yu
Oncogene|May 7, 2021
C/EBPβ is a MYB- and p300-cooperating pro-leukemogenic factor and promising drug target in acute myeloid leukemiaMaria V Yusenko, Amke Trentmann, Debora A Casolari, et al.
Oncogene|May 7, 2021
YTHDF2 is a potential target of AML1/ETO-HIF1α loop-mediated cell proliferation in t(8;21) AMLZe Chen, Yang-Liu Shao, Li-Li Wang, et al.
Oncogene|May 7, 2021
Correction: Role of androgen receptor splice variant-7 (AR-V7) in prostate cancer resistance to 2nd-generation androgen receptor signaling inhibitorsYezi Zhu, Susan L Dalrymple, Ilsa Coleman, et al.
Pageof 2,257